CIncinnati, Ohio Pharmaceutical contamination attorney and Losartan lawyer investigating Losartan recall lawsuits and suspected cancer risks due to laboratory and drug company negligence
Another round of drug recalls has been issued by the FDA, naming common blood pressure and heart failure medications containing losartan, valsartan and irbesartan. The recalls are due to impurities from N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), as well as NDMA and NDEA, which are classified as a potential human carcinogen.
The FDA says the investigation has already identified thousands of tainted drugs and more are likely to be discovered by safety authorities.
The U.S. Food and Drug Administration noted in a news release that Camber Pharmaceuticals Inc. has thus far recalled 87 lots of losartan tablets. The recalled tablets were manufactured by Hetero Labs Ltd. in India and distributed by Camber Pharmaceuticals. Camber has not received any reports of adverse events related to the recalled drugs, though cancer risks are clearly a concern.
The Camber Pharmaceutical recall is only the latest in a huge investigation into the entire class of drugs known as angiotensin receptor blockers (ARBs), which contain either valsartan, losartan or irbesartan.
Joe Lyon is a highly-rated Cincinnati, Ohio product liability attorney and Losartan lawyer investigating Losartan recall lawsuits and cancer risks for plaintiffs nationwide.
The Lyon Firm has experience engaging pharmaceutical companies following recalls and pharmaceutical negligence.
Ohio Losartan Lawyer Reviews Contamination
Beginning in July 2018, several lots of ARB blood pressure and heart failure medications manufactured with losartan, valsartan and irbesartan from various companies were recalled for containing traces of potential human carcinogens, including N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA).
The current FDA analyses of NDMA and NDEA note a low risk for developing cancer, though any added risk is reason enough for a recall and losartan recall lawsuits targeting several drug makers including the following:
- Camber Pharmaceuticals
- A-S Medication Solutions LLC
- Bryant Ranch Prepack Inc.
- Northwind Pharmaceuticals
- Prinston Pharmaceuticals—Solco Healthcare
- Teva Pharmaceuticals
Does Losartan Cause Cancer?
NDMA, or N-nitrosodimethylamine, has been classified as a “probable carcinogen” by the FDA. NDMA has no approved uses in the United States, and the chemicals NDEA and NBMA also have carcinogenic properties. Toxicologists agree the dose and duration of NDMA exposure determines if a Valsartan patient’s cancer can be attributed to the contaminated drug.
Some patients will have consumed enough NDMA in contaminated Valsartan and Losartan that their risk for certain cancers like digestive tract cancers, liver cancer, kidney cancer, stomach cancer, and colorectal cancer rises dramatically.
Not all ARB products are contaminated or contain NDMA, NDEA or NMBA impurities, so patients should ask their doctor about an alternative medication unaffected by the Losartan and Valsartan recalls. The U.S. Food and Drug Administration (FDA) has reported that it is continuing its investigation and product liability attorneys are filing Losartan recall lawsuits to hold companies liable for their negligence.
Contact a Valsartan Cancer Lawyer if:
- You have been diagnosed with a qualifying cancer at least ONE YEAR after taking Valsartan or a contaminated Losartan. If you are unsure whether your medication was contaminated or not, contact an attorney to assist in reviewing the National Drug Code records.
- You have a diagnosis of: kidney cancer, liver cancer, colon cancer, stomach cancer, or intestinal cancer
- You have been diagnosed with cancer AFTER 2014
- You were taking Losartan or Irbesartan for at least one year prior to cancer diagnosis
- You have received recall letter OR have drug records with a recalled NDC number.
- If you have NOT received a recall letter, please order your drug records dating back to 2014 to current
Losartan Recalls & Contamination Hazards
The FDA has expressed concerns over Valsartan’s and Losartan’s “genotoxic impurities,” which can cause harm at trace levels. When consumers and patients are harmed by contaminated medications due to the negligence of drug companies, the companies can be held liable for the disregard of consumer health.
If you have been diagnosed with liver cancer, kidney cancer, stomach cancer, intestinal cancer or colon cancer, contact a Losartan lawyer to review your particular case and pending class action lawsuits.
Camber Pharma and other manufacturers have a duty to mind the well-being of consumers, and should they fail to do so, they may face losartan recall lawsuits, personal injury and product liability claims.
If you or a loved one has suffered a losartan drug injury, and have questions about the legal remedies available to improve quality of life and medical care, contact The Lyon Firm at (800) 513-2403. You will speak directly with Mr. Lyon, a Losartan lawyer, and he will help you answer critical questions regarding Ohio Losartan recall lawsuits.